Experimental Electric Implant Regulates Blood Sugar and Triggers Weight Loss in Diabetic Mice
A new inorganic implant uses electricity to turn excess glucose into a removable compound, lowering blood sugar and causing weight loss in early mouse trials.
Electricity‑Driven Diabetes Therapy
Imagine a tiny device that zaps excess sugar out of the bloodstream.
Scientists led by Martin Fussenegger, a professor in the Department of Biosystems Science and Engineering at ETH Zurich, have reported a new electronic implant that lowers blood glucose without insulin or conventional drugs.
The findings appear in Science and describe an implant that converts surplus glucose into gluconate, a compound the body can excrete in urine.
How it works
The core of the device is a piece of graphite felt coated with clusters of gold, which are further covered by tiny platinum particles. This engineered nanoscale surface catalyzes the chemical reaction that transforms glucose into gluconate.
All components are inorganic; no living cells, enzymes or other biological materials are required.
The implant includes an electronic controller housed in a 3D‑printed case. Power is delivered wirelessly at a frequency of 13.56 MHz, a band reserved internationally for industrial, scientific and medical uses.
Automatic response
According to the researchers, the system detects rising blood‑sugar levels and initiates the conversion process without external input.
In early experiments with diabetic mice, the implant successfully regulated glucose concentrations and the animals also showed weight loss.
Biocompatibility tests indicated that the materials interact with tissue without causing significant adverse reactions.
While the technology is still experimental, the study suggests a novel, electricity‑based approach to managing type 2 diabetes.
